Quantitative analysis of drug-receptor interactions: I. Determination of kinetic and equilibrium properties.
about
Munc18-1 regulates early and late stages of exocytosis via syntaxin-independent protein interactionsPsychotomimetic opiate receptors labeled and visualized with (+)-[3H]3-(3-hydroxyphenyl)-N-(1-propyl)piperidineBiochemical and pharmacological characterization of serotonin-O-carboxymethylglycyl[125I]iodotyrosinamide, a new radioiodinated probe for 5-HT1B and 5-HT1D binding sitesCharacterization of the binding of a novel radioligand to CCKB/gastrin receptors in membranes from rat cerebral cortexThe Mycobacterium tuberculosis membrane protein Rv2560--biochemical and functional studiesThymosin beta 4 sequesters the majority of G-actin in resting human polymorphonuclear leukocytesSolubilization of a tamoxifen-binding protein. Assessment of its molecular mass.Multiple drugbinding sites on the R482G isoform of the ABCG2 transporter.Turn-on switch in parathyroid hormone receptor by a two-step parathyroid hormone binding mechanism.Potent interleukin 3 receptor agonist with selectively enhanced hematopoietic activity relative to recombinant human interleukin 3Quantitative autoradiography of brain binding sites for the vesicular acetylcholine transport blocker 2-(4-phenylpiperidino)cyclohexanol (AH5183).Alpha-1 adrenoceptors: evaluation of receptor subtype-binding kinetics in intact arterial tissues and comparison with membrane bindingInhibition of myocardial Ca2+ channels by three dihydropyridines with different structural features: potential-dependent blockade by Ro 18-3981.(+)-[3H]-PN 200-110 binding to cell membranes and intact strips of portal vein smooth muscle: characterization and modulation by membrane potential and divalent cations.Identification of a novel calcium antagonist binding site in rat brain by SR 33557Angiotensin converting enzyme binding sites in human heart and lung: comparison with rat tissuesInvestigations into factors determining the duration of action of the beta 2-adrenoceptor agonist, salmeterol.Effect of dihydropyridines on calcium channels in isolated smooth muscle cells from rat vena cava.Pharmacological analysis of [3H]-senktide binding to NK3 tachykinin receptors in guinea-pig ileum longitudinal muscle-myenteric plexus and cerebral cortex membranes.Differentiation of receptor subtypes by thermodynamic analysis: application to opioid delta receptors.Enhanced binding of peptide antigen to purified class II major histocompatibility glycoproteins at acidic pH.Serotonin binds specifically and saturably to an actin-like protein isolated from rat brain synaptosomesRadioligand and functional estimates of the interaction of the 1,4-dihydropyridines, isradipine and lacidipine, with calcium channels in smooth muscle.Relation between alpha 1-adrenoceptor subtypes and noradrenaline-induced contraction in rat portal vein smooth muscle.Divalent cation competition with [3H]saxitoxin binding to tetrodotoxin-resistant and -sensitive sodium channels. A two-site structural model of ion/toxin interaction.Apparent competitive inhibition of radioligand binding to receptors: experimental and theoretical considerations in the analysis of equilibrium binding data.Quantitative autoradiography of [3H]indalpine binding sites in the rat brain: I. Pharmacological characterization.Kinetics of G-protein-coupled receptor signals in intact cellsRecombinant human nerve growth factor is biologically active and labels novel high-affinity binding sites in rat brain.Therapeutic management of allergic diseases.From pharmacokinetics to therapeutics.Solubilization of a thromboxane A2/prostaglandin H2 antagonist binding site from human platelets.(-)-S-[3H]CGP-12177 and its use to determine the rate constants of unlabeled beta-adrenergic antagonists.Recent advances in receptor research.Identifying Plasmodium falciparum cytoadherence-linked asexual protein 3 (CLAG 3) sequences that specifically bind to C32 cells and erythrocytes.Characterization of the binding of [3H]-clobenpropit to histamine H3-receptors in guinea-pig cerebral cortex membranesPeptides derived from Mycobacterium tuberculosis Rv2301 protein are involved in invasion to human epithelial cells and macrophages.A comprehensive method for the quantitative determination of dopamine receptor subtypes.Role of the proposed pore-forming segment of the Ca2+ release channel (ryanodine receptor) in ryanodine interaction.Identification of three gp350/220 regions involved in Epstein-Barr virus invasion of host cells.
P2860
Q24557450-CCFE37E4-2D37-4CE7-AC01-F1AF4EE99B10Q24608102-B95AF360-6C3A-4B47-BA2D-971A03FE180DQ28324576-90DA5CC6-8F5C-4388-880B-CA5B2349AF90Q28343282-23ED487A-D5DF-468B-8013-ECEB7898E969Q28486656-9702C75C-15F1-4E9A-86C8-016F94539648Q28910318-5402966E-5330-4775-B92F-3DCF8099753BQ30403555-2BD18DC0-9AF0-4535-A2FB-04AEAFDADAE6Q33257856-FFBA47D5-32D5-4980-B447-C9885342FD09Q34115829-5C4A9991-01E9-4816-A6E2-0FC941918BF2Q34377607-FCA08AAB-4C15-42AE-B293-F15D606BF0DBQ34594531-D098374F-FA96-4269-83E4-10B150F6FE48Q35046091-8C29A8DE-D7C2-46F4-ACB0-21720582139EQ35754720-CBF2C889-6C8F-4BE5-9B66-A03A9901726AQ35756415-928A6C86-9D6D-4F46-8AA3-225B3587A944Q35870980-F7F1D1C4-DCEE-424E-AAD4-C3739A0B1650Q35871055-2F3A6374-590F-4709-9EE4-1F2DFEB14FE4Q35871413-049AE8AA-C336-4A6C-8C44-4FA0919D1495Q35872385-316F4123-6B6D-4F36-BBAF-A36093A5F1CCQ35888087-DED7F9E6-C4D7-44AC-AA49-2C3EDB268BB6Q35954096-B752B1A4-B463-46C0-8B8A-F64B88773DF1Q36230523-E796E426-AE77-4780-BBC0-170B217D7EC2Q36254861-A3F922C6-62FA-466C-B225-079D0A2613AEQ36329438-14D0763E-0583-48FD-9A89-A0B09BE3C3A4Q36330387-A625600A-937D-4BF1-9FB9-78BFB17CD020Q36411341-84098A1E-8727-400D-817E-4ECC0AD7C2BBQ36438256-E167ECF8-0340-46BB-9D67-76A0C27BAD0FQ36487594-A5F69039-9690-404C-99A1-5C17C7F59199Q37056211-C5C1DFC1-A049-476E-8BEB-463461873D33Q37365111-AB1D6E79-4E59-4AA5-9B6B-BC461EBC0B38Q37550543-7D9AD514-DEE3-47C5-9BD7-DB14B793664EQ37550564-782B479A-275F-43CB-8009-4DE1D57840EFQ37554210-F597A5FE-4680-4224-B2BC-9027761B8AFEQ37677322-713B7207-7224-4FBA-B562-963A3FDC20F3Q38316475-D9986195-99A1-4718-A98C-97531FD829B4Q38331745-C06FE48C-0D82-4298-9FCD-B17CB8F0C999Q38527111-22D42830-1687-498D-B1C3-531B61612261Q39540019-A1285F54-1BF3-46DF-871B-1B72EE3075DBQ40143480-F3D03CF4-C287-405B-BA8F-B05E7414CBD5Q40205990-98792D3E-5332-49C6-9EEC-65C39E1FBE4BQ40387241-1DEDB2B4-0BD5-4D4D-A4D8-9012F0BFA987
P2860
Quantitative analysis of drug-receptor interactions: I. Determination of kinetic and equilibrium properties.
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
1981年论文
@zh
1981年论文
@zh-cn
name
Quantitative analysis of drug- ...... ic and equilibrium properties.
@en
type
label
Quantitative analysis of drug- ...... ic and equilibrium properties.
@en
prefLabel
Quantitative analysis of drug- ...... ic and equilibrium properties.
@en
P1433
P1476
Quantitative analysis of drug- ...... ic and equilibrium properties.
@en
P2093
Molinoff PB
Weiland GA
P304
P356
10.1016/0024-3205(81)90324-6
P407
P577
1981-07-01T00:00:00Z